drugset / Trial / NCT02609490
Azilsartan in Chinese Patients With Mild and Moderate Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
A phase 3 clinical study to evaluate the safety and efficacy of Azilsartan in Chinese hypertension patients
Timeline
- Start
- 2015-09
- Primary completion
- 2017-02
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan | Unknown | 20 mg | — |
| Comparator | Olmesartan medoxomil | Unknown | 20 mg | — |